What’s in a (drug) name? FDA to study how they af­fect ef­fi­ca­cy per­cep­tions

When it comes to pro­pri­etary drug names over­stat­ing their ef­fi­ca­cy, taint­ed sex­u­al en­hance­ment prod­ucts dis­guised as sup­ple­ments may take the cake (see: “2 Own The Knight” or “XXXPlo­sion Ul­tra”).

For the le­git­i­mate phar­ma­ceu­ti­cal world, the FDA wants to take a clos­er look at how cer­tain brand names af­fect con­sumer and health care providers’ per­cep­tions about ef­fi­ca­cy and the med­ical con­di­tions for which they’re in­di­cat­ed.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

Venture & Research Associate

Alexandria Real Estate Equities

San Francisco, CA, USA